May 2, 2011 writer

TSO3 to Disclose First Quarter 2011 Financial Results and Hold Annual General Meeting of Shareholders May 11, 2011

Quebec City, May 2, 2011 – TSO3 Inc. (“TSO3”) (TSX: TOS) will report first quarter (Q1) 2011 financial results, for the period ending March 31, 2011 and hold its fiscal 2010 Annual General Meeting of Shareholders on Wednesday May 11, 2011.

TSO3 will host a Conference Call and a Webcast at 10:30 A.M. (EDST) the same day to discuss Q1 2011 financial results. Analysts and Institutional Investors are invited to participate in the call and the numbers to dial for access are 514 940-2795 (Montréal area), 416 644-3424 (Toronto area) or the Toll-Free number 1-800-594-3790.

The Annual General Meeting of Shareholders will be held at the McCord Museum (J. Armand-Bombardier Theatre), 690 Sherbrooke Street West, Montreal (Québec) at 3:00 P.M. (EDST).

To listen to the live webcasts of these events, login via TSO3‘s website, in the “Investors” section, under the item “Webcasts” (https://www.tso3.com/en/investors/financial-reports-webcasts.php). The Webcasts will be archived for a 90-day period.

About TSO3

TSO3, founded in Québec City in 1998, specializes in the research and development of innovative, high-performance medical instrument sterilization technology with high commercial potential.  TSO3 designs products for sterile processing areas in the hospital environment and offers an advantageous replacement solutions to other low temperature sterilization processes currently used in hospitals.

The statements in this release and oral statements made by representatives of TSO3 relating to matters that are not historical facts (including, without limitation, those regarding the timing or outcome of any financing undertaken by TSO3) are forward-looking statements that involve certain risks, uncertainties and hypotheses, including, but not limited to, general business and economic conditions, the condition of the financial markets, the ability of TSO3 to obtain financing on favourable terms and other risks and uncertainties.

The TSX has neither approved nor disapproved the information contained herein and accepts no responsibility for it.

-30-

Back to Posts